Prenatal Cocaine Exposure and Cardiometabolic Disease Risk Factors in 18- to 20-Year-Old African Americans

Area of Science:

• Cardiovascular Science
• Developmental Pediatrics
• Public Health

Background:

• Long-term physical health effects of prenatal cocaine exposure (PCE) remain largely unexamined.
• No human studies have confirmed or refuted a link between PCE and long-term cardiovascular or metabolic disease risk.
• Investigating PCE's impact on cardiometabolic risk factors in young adults is crucial.

Purpose of the Study:

• To examine the association between prenatal cocaine exposure (PCE) and primary cardiometabolic disease risk factors.
• To assess PCE's impact on cardiovascular and metabolic health in African American (AA) adolescents aged 18 to 20 years.

Main Methods:

• A longitudinal, prospective cohort study design was employed.
• Participants included 350 healthy, full-term inner-city African American adolescents (aged 18–20 years) enrolled at birth (1990–1993).
• Evaluated fasting serum insulin, glucose, lipids, high-sensitivity C-reactive protein, blood pressures, and metabolic syndrome components.

Main Results:

• No significant differences in cardiometabolic disease risk factors were observed between individuals with and without prenatal cocaine exposure (PCE).
• The prevalence of metabolic syndrome and its individual components did not differ based on PCE status.
• No PCE-associated differences in serum lipids, glucose, insulin, or blood pressure were found.

Conclusions:

• The study findings do not support an association between prenatal cocaine exposure (PCE) and increased cardiometabolic disease risk in young adult African Americans.
• Further investigation is warranted to determine if PCE is associated with cardiovascular or metabolic disease later in adulthood.